Add mass spectrometry to the pandemic toolbox.

Van Puyvelde, Bart; Dhaenens, Maarten

Van Puyvelde, Bart; Dhaenens, Maarten.

Affiliation

Van Puyvelde B; Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium.
Dhaenens M; ProGenTomics, Ghent, Belgium.

Elife ; 102021 12 10.

Article in En | MEDLINE | ID: mdl-34889738

ABSTRACT

ABSTRACT

A new protocol step improves robustness and ease-of-use for mass spectrometry in the clinic, opening the door to mass deployment to monitor infectious agents.

Subject(s)

COVID-19; Pandemics; Humans; Mass Spectrometry; Proteomics; SARS-CoV-2

Key words

Covid-19; SARS-CoV-2; diagnostics; human; immunology; infectious disease; inflammation; mass spectrometry; microbiology; proteomics; public health

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pandemics / COVID-19 Type of study: Guideline Limits: Humans Language: En Journal: Elife Year: 2021 Type: Article Affiliation country: Belgium

Fulltext

XML

PubMed Links

Search on Google